David C. Oxley
Directeur/Membre du Conseil chez TB Biosciences, Inc.
Postes actifs de David C. Oxley
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
TB Biosciences, Inc.
 TB Biosciences, Inc. Medical/Nursing ServicesHealth Services TB Biosciences, Inc. operates as a early stage development medical diagnostics company which develops a rapid point-of-care tuberculosis tests. It uses key peptides to detect antibodies in patients with active tuberculosis derived from the genome of the tuberculosis organism, thus offering a completely new approach to testing. The firm is using an array of patented peptides developed and exclusively licensed from the New York university school of medicine. The company was founded by Daniel Malamud, Susan Zolla-Pazner, Suman Laal, R. Sam Niedbala and William Abrams in May 2013 and is headquartered in Bethlehem, PA. | Directeur/Membre du Conseil | 01/08/2013 | - |
Historique de carrière de David C. Oxley
Anciens postes connus de David C. Oxley
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| EXOPHARM | President | 01/08/2021 | 01/01/2023 |
| TRINITY BIOTECH PLC | Sales & Marketing | - | - |
| PLUS THERAPEUTICS, INC. | Sales & Marketing | 21/05/2010 | - |
Statistiques
Internationale
| Etats-Unis | 3 |
| Irlande | 2 |
| Australie | 2 |
Opérationnelle
| Sales & Marketing | 2 |
| Director/Board Member | 1 |
| President | 1 |
Sectorielle
| Health Technology | 4 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PLUS THERAPEUTICS, INC. | Health Technology |
| TRINITY BIOTECH PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
TB Biosciences, Inc.
TB Biosciences, Inc. Medical/Nursing ServicesHealth Services TB Biosciences, Inc. operates as a early stage development medical diagnostics company which develops a rapid point-of-care tuberculosis tests. It uses key peptides to detect antibodies in patients with active tuberculosis derived from the genome of the tuberculosis organism, thus offering a completely new approach to testing. The firm is using an array of patented peptides developed and exclusively licensed from the New York university school of medicine. The company was founded by Daniel Malamud, Susan Zolla-Pazner, Suman Laal, R. Sam Niedbala and William Abrams in May 2013 and is headquartered in Bethlehem, PA. | Health Services |
Exopharm Ltd.
 Exopharm Ltd. Pharmaceuticals: MajorHealth Technology Exopharm Ltd. engages in the research and development of biopharmaceutical drugs. The company was founded by Ian Dixon and Gregor Lichtfuss in 2013 and is headquartered in Camberwell, Australia. | Health Technology |
- Bourse
- Insiders
- David C. Oxley
- Expérience
